Letter
Ethnic misclassifications hamper progress in research
Cite this as:
BMJ
2006;332:1335.1
- Charles Agyemang (c.o.agyemang@amc.uva.nl), associate researcher
- Amsterdam Medical Centre, Department of Social Medicine, 1100 DD, Amsterdam
EDITOR—McDowell et al review the evidence for ethnic differences in susceptibility to adverse drug reactions to cardiovascular drugs.1 They concluded that patients from different ethnic groups have different risks for adverse reactions to cardiovascular drugs and that ethnic group may be one determinant of harms of a given treatment, either because it acts as a surrogate measure …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: How much of a social media profile can doctors have?
Published 13 February 2012
Re: Diagnosis and management of Raynaud’s phenomenon
Published 13 February 2012
Re: Is it unethical for doctors to encourage healthy adults to donate a kidney to a stranger? No
Published 13 February 2012
Re: Report predicts 20 million AIDS orphans in Africa by 2010
Published 13 February 2012
Re: On the impossibility of being expert
Published 13 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (8 responses)
Published 27 Jan 2012
How much of a social media profile can doctors have? (7 responses)
Published 23 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012